We’d love your feedback!

We’re working on new tools and we want to make sure they’re truly useful to you.

Can you spare 30 seconds to answer 3 quick questions?

Your feedback directly shapes the future of Finviz.

Take the Survey

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 20 04:00PM ET
21.69
Dollar change
-0.30
Percentage change
-1.36
%
IndexRUT P/E15.79 EPS (ttm)1.37 Insider Own0.78% Shs Outstand167.12M Perf Week26.10%
Market Cap3.63B Forward P/E25.41 EPS next Y0.85 Insider Trans-1.88% Shs Float166.05M Perf Month50.83%
Income228.88M PEG3.83 EPS next Q0.14 Inst Own103.76% Short Float9.19% Perf Quarter10.27%
Sales996.28M P/S3.64 EPS this Y-61.77% Inst Trans14.50% Short Ratio7.28 Perf Half Y27.44%
Book/sh4.58 P/B4.74 EPS next Y64.21% ROA23.03% Short Interest15.26M Perf Year46.06%
Cash/sh4.07 P/C5.33 EPS next 5Y4.12% ROE37.24% 52W Range13.40 - 25.23 Perf YTD18.20%
Dividend Est.- P/FCF24.45 EPS past 5Y- ROI28.26% 52W High-14.03% Beta0.69
Dividend TTM- Quick Ratio2.80 Sales past 5Y23.80% Gross Margin92.04% 52W Low61.87% ATR (14)1.21
Dividend Ex-Date- Current Ratio2.88 EPS Y/Y TTM11860.68% Oper. Margin8.87% RSI (14)77.73 Volatility10.85% 6.19%
Employees654 Debt/Eq0.07 Sales Y/Y TTM22.42% Profit Margin22.97% Recom1.95 Target Price25.89
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q13.88% Payout0.00% Rel Volume1.39 Prev Close21.99
Sales Surprise2.32% EPS Surprise26.87% Sales Q/Q18.70% EarningsMay 07 AMC Avg Volume2.10M Price21.69
SMA2030.81% SMA5033.47% SMA20029.93% Trades Volume2,923,173 Change-1.36%
Date Action Analyst Rating Change Price Target Change
Feb-11-25Initiated Deutsche Bank Hold $22
Jan-03-25Downgrade Guggenheim Buy → Neutral $23 → $20
Oct-10-24Resumed Raymond James Mkt Perform
Aug-07-24Downgrade Morgan Stanley Overweight → Equal-Weight $28 → $20
Jun-27-24Initiated BMO Capital Markets Outperform $31
Mar-12-24Reiterated Needham Buy $36 → $32
Mar-12-24Downgrade Mizuho Buy → Neutral $39 → $25
Jan-30-24Initiated Robert W. Baird Outperform $40
Jan-24-24Upgrade Needham Hold → Buy $37
Dec-19-23Upgrade Morgan Stanley Equal-Weight → Overweight $31 → $40
Today 04:05PM
12:52PM
10:55AM
May-19-25 03:07PM
11:40AM
09:32AM Loading…
09:32AM
May-17-25 01:36PM
01:36PM
May-16-25 01:43PM
May-09-25 06:26PM
May-08-25 10:40AM
08:03AM
03:28AM
May-07-25 08:10PM
08:10PM
05:35PM Loading…
05:35PM
04:30PM
04:05PM
10:00AM
May-05-25 04:05PM
11:12AM
10:00AM
09:40AM
09:13AM
Apr-30-25 10:01AM
Apr-23-25 04:05PM
Apr-15-25 10:20AM
Apr-11-25 04:05PM
Apr-10-25 02:37PM
09:31AM
11:30AM Loading…
Mar-28-25 11:30AM
Mar-27-25 02:50PM
08:46AM
Mar-25-25 05:40PM
Mar-21-25 09:20AM
Mar-17-25 03:39PM
Mar-14-25 04:05PM
Mar-13-25 04:05PM
Mar-05-25 09:05AM
06:36AM
Mar-03-25 09:05AM
Feb-28-25 12:01PM
Feb-27-25 04:05PM
12:01PM
Feb-26-25 05:25PM
04:35PM
04:05PM
Feb-14-25 04:05PM
Feb-13-25 08:30AM
Feb-12-25 04:05PM
Jan-17-25 04:05PM
Jan-14-25 01:10PM
09:05AM
09:00AM
Jan-12-25 09:33AM
Jan-02-25 02:58AM
Dec-30-24 05:37PM
05:37PM
Dec-19-24 04:05PM
Dec-16-24 04:05PM
Dec-11-24 04:05PM
Dec-09-24 09:00AM
Dec-03-24 09:50AM
08:32AM
Nov-27-24 07:06AM
Nov-26-24 04:05PM
Nov-21-24 04:05PM
Nov-15-24 04:05PM
Nov-12-24 09:50AM
Nov-07-24 06:00AM
Nov-06-24 05:15PM
04:13PM
04:05PM
Nov-05-24 04:05PM
Oct-31-24 02:22PM
Oct-17-24 06:41PM
07:28AM
Oct-16-24 04:07PM
Oct-08-24 04:05PM
Sep-26-24 04:05PM
Sep-23-24 04:15PM
Aug-29-24 08:30AM
Aug-28-24 04:05PM
Aug-14-24 08:04AM
Aug-07-24 04:30PM
04:14PM
08:16AM
Aug-06-24 05:45PM
04:42PM
04:05PM
Jul-30-24 10:01AM
Jul-24-24 04:05PM
Jul-18-24 09:04AM
Jul-16-24 10:28AM
Jun-21-24 12:24PM
10:53AM
Jun-18-24 09:04AM
Jun-07-24 11:30AM
May-29-24 10:01AM
May-17-24 04:05PM
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMay 16 '25Sale22.504,00090,00020,395May 19 08:52 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMay 16 '25Sale25.002,00050,00062,130May 19 08:50 PM
Schneyer Mark C.OfficerMay 16 '25Proposed Sale17.602,00035,200May 16 05:10 PM
Kihara JamesOfficerMay 16 '25Proposed Sale17.604,00070,400May 16 05:06 PM
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMay 02 '25Sale14.601,32719,37423,526May 02 08:00 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMay 02 '25Sale14.603,49851,07162,773May 02 07:59 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERApr 08 '25Sale14.822,70840,13359,456Apr 08 07:40 PM
Kihara JamesPRINCIPAL ACCOUNTING OFFICERApr 08 '25Sale14.821,02815,23522,257Apr 08 07:38 PM
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMar 26 '25Sale17.051,09518,67021,275Mar 26 08:10 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMar 26 '25Sale17.053,17154,06656,889Mar 26 08:06 PM
GAROFALO ELIZABETH A.DirectorMar 05 '25Sale18.234,91989,67317,595Mar 06 06:30 PM
GAROFALO ELIZABETH A.DirectorMar 05 '25Proposed Sale18.234,91989,673Mar 06 12:17 PM
Kihara JamesPRINCIPAL ACCOUNTING OFFICERFeb 24 '25Sale19.964759,48120,228Feb 25 06:48 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERFeb 24 '25Sale19.9677315,42953,882Feb 25 06:46 PM
Teehan BrendanEVP, COO, HEAD OF COMMERCIALNov 19 '24Sale16.8110,329173,63062,105Nov 19 08:43 PM
Kihara JamesPRINCIPAL ACCOUNTING OFFICERNov 19 '24Sale16.814,07368,46719,863Nov 19 08:41 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERNov 19 '24Sale16.8110,259172,45453,302Nov 19 08:40 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERAug 19 '24Sale15.289,733148,72043,735Aug 20 06:46 PM
Teehan BrendanEVP, COO, HEAD OF COMMERCIALAug 19 '24Sale15.289,534145,68052,177Aug 20 06:43 PM
DAVIS STEPHENCEOAug 19 '24Sale15.2831,747485,094186,555Aug 20 06:40 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERJun 10 '24Sale14.7997514,42034,564Jun 11 06:00 PM